Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: A quantitative evaluation

Cancer Letters

Volumn 167, Issue 2, 2001, Pages 183-191

  Wong, Ivy H N ^a,b   Yeo, Winnie ^a   Leung, Thomas ^a   Lau, Wan Y ^a   Johnson, Philip J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Albumin mRNA; Alpha fetoprotein mRNA; Metastasis; Recurrence; Semi quantitative reverse transcription polymerase chain reaction

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; MESSENGER RNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR CELL;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; NEOPLASM CIRCULATING CELLS; PROGNOSIS; RNA, MESSENGER; SERUM ALBUMIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035954236     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00455-4     Document Type: Article

References (31)

1. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
2. Postoperative recurrence of hepatocellular carcinoma
3. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction
4. Hematogenous dissemination of hepatocytes and tumor cells following surgical resection of hepatocellular carcinoma: A quantitative analysis
5. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific mRNA markers: A pilot study
6. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: Potential prognostic implications
7. Quantitative relationship of the circulating tumor burden assessed by RT-PCR for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Duke's stage, serum carcinoembryonic antigen level and tumor progression
8. Molecular analysis of circulating tumour cells in peripheral blood from patients with germ cell tumor: A quantitative approach
9. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
10. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinoma
11. Illegitimate transcription: Transcription of any gene in any cell type
12. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction
13. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation
14. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: Implications in cancer detection and monitoring
15. Well-differentiated hepatocellular carcinoma: Clinicopathological features and results of hepatic resection
16. Personal experience with 411 hepatic resections
17. Routine angiography following partial hepatectomy in patients with malignant lesions of the liver
18. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy
19. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma
20. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation
21. The 'seed and soil' hypothesis and the decline of radical surgery: A surgeon's opinion
22. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy
23. Promotion of hepatic metastases by liver resection in the rat
24. Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats
25. Hepatocyte growth factor: A multifunctional cytokine
26. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis
27. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
28. Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients: Implications for cancer detection and monitoring
29. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients
30. Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients
31. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma